MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-14-2026
Novartis AG DIO Ratio 2011-2026 | NVS
Annual DIO Ratio Novartis AG
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 130 | 131 | 128 | 135 | 131 | 114 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 135 | 114 | 128 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Amgen
AMGN
|
200 | $ 350.17 | 0.68 % | $ 188 B |  USA |
 |
Amphastar Pharmaceuticals
AMPH
|
166 | $ 19.57 | 0.36 % | $ 915 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | USA |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Aytu BioScience
AYTU
|
209 | $ 2.64 | 1.15 % | $ 16.6 M | USA |
 |
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M |  Canada |
 |
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | USA |
 |
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | USA |
 |
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | Canada |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
Coherus BioSciences
CHRS
|
97.5 | $ 1.58 | 3.62 % | $ 185 M | USA |
 |
Cellectis S.A.
CLLS
|
23.3 | $ 3.35 | 0.3 % | $ 116 M |  France |
 |
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | USA |
 |
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
CorMedix
CRMD
|
308 | $ 6.29 | 0.64 % | $ 453 K | USA |
 |
Clovis Oncology
CLVS
|
271 | - | -7.23 % | $ 13 M | USA |
 |
Dyadic International
DYAI
|
161 | $ 0.89 | -5.85 % | $ 25.6 M | USA |